Vikram is a neuroscientist, investor, entrepreneur and industry veteran with nearly 25 years of industry experience. Most recently, Vikram was CEO of Cipla Technologies and built a pipeline of branded products to treat CNS disorders and respiratory diseases. Prior to that, Vikram was head of Strategy for Cipla New Ventures. Vikram’s career experience spans a wide spectrum of industry functions including venture capital, business development, transactions, market access, drug idea generation, drug development and operations. Vikram served on the boards of Stempeutics, Chase Pharmaceuticals, Cipla Technologies and Cipla USA. Vikram received his PhD from the University of Sheffield and completed his post-doctorate at Stanford University School of Medicine.